HRS-6768
- Generic Name
- HRS-6768
A Trial of HRS-6768 in Patients With Advanced Solid Tumors
- First Posted Date
- 2025-04-13
- Last Posted Date
- 2025-05-14
- Lead Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Target Recruit Count
- 84
- Registration Number
- NCT06925581
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath